Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society.
Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. The applications of these technologies are broad and include increasing the longevity and function of transplanted vascular grafts and cell-based therapies, promoting healing of chronic skin wounds, developing improved breast cancer drugs, and treating osteoarthritis.
He is a professor of biomedical engineering, a fellow in the Vanderbilt Interdisciplinary Graduate Program in Materials Science, an advisory board member of the Vanderbilt Institute of Nanoscale Science and Engineering, and a member of the Vanderbilt Diabetes Research and Training Center.
Duvall, who joined the Vanderbilt engineering faculty in 2010, is the biomedical engineering department’s Director of Undergraduate Studies and a former member of the university’s Graduate Faculty Council. He is an accomplished teacher and mentor to both undergraduate and graduate students.
Major awards include a National Science Foundation Early Career Development Award in 2014; a Presidential Early Career Award for Scientists and Engineers in 2017; and a Chancellor Faculty Fellowship in 2018. He was selected as a Fellow of the American Institute for Medical and Biological Engineering in 2018 and was named Cornelius Vanderbilt Professor of Engineering earlier this year.
Full article Here.